Righton Biology, a specialized molecular diagnostics company with test kits for leukemia, lymphoma, and solid tumors, today announced that it had completed its Series A financing.
Xingshulin, a leading mobile app focused on providing data and management tools to physicians across the country, announced today that it had completed Series C financing.
ET Healthcare, an advanced in-vitro diagnostic technology company, announced today that it had completed a new round of financing, led by Qiming Venture Partners and Masion Capital with participation from the compan's existing shareholders Legend Capital
Sino-Kor Plastics Surgery Hospital (NEEQ: 430335), China's largest clinic and hospital chain in plastic surgery listed on China's New Third Board, announced today that it had completed a secondary offering to finance expansion of new hospitals and clinics
Xingren Doctor, a leading mobile platform for doctors in China, announced today that it had raised RMB 200 million in one of the largest Series B rounds in the mobile healthcare space.